Alzheimer's Research UK

Last updated

Alzheimer's Research UK
Type Charitable organisation
Focus Alzheimer's disease research
Health policy
Key people
Hilary Evans (Chief Executive)
Website www.alzheimersresearchuk.org
Formerly called
Alzheimer's Research Trust

Alzheimer's Research UK (ARUK) is a dementia research charity in the United Kingdom, founded in 1992 as the Alzheimer's Research Trust.

Contents

ARUK funds scientific studies to find ways to treat, cure or prevent all forms of dementia, including Alzheimer's disease, vascular dementia, dementia with Lewy bodies and frontotemporal dementia.

As of 2019, Alzheimer's Research UK has funded 139 research projects across the UK and internationally, and has committed more than £117 million to dementia research. [1]

Alzheimer's Research UK is a member of the Association of Medical Research Charities.

History

Tanith Lee raising money for the Alzheimer's Research Trust as part of the Match It For Pratchett campaign 2011 Tanith Lee signing.jpg
Tanith Lee raising money for the Alzheimer's Research Trust as part of the Match It For Pratchett campaign 2011

In 1998, the trust awarded its first major grant of £500,000 to a team led by distinguished scientist Dr Michel Goedert in Cambridge. At that time the charity funded over 100 grants all over the UK at a cost of more than £11 million. [2]

In March 2008, author Terry Pratchett, who had the disease, donated one million US dollars to the trust. [3]

In 2009 Alzheimer's Research Trust scientists discovered two new genes related to Alzheimer's. Over 16,000 people took part in this study.[ citation needed ] Time magazine wrote that the findings were one of the most important medical discoveries of the year.[ citation needed ]

In February 2010, the Alzheimer's Research Trust released the Dementia 2010 report, revealing new evidence of the prevalence, economic cost and research funding for dementia and other major conditions. [4] [5]

In February 2011 Alzheimer's Research Trust was renamed as Alzheimer's Research UK.[ citation needed ]

In 2016, Alzheimer's Research UK became a founding funder of the UK Dementia Research Institute, a £290 million joint investment with the Medical Research Council and Alzheimer's Society. [6]

In 2017, former Prime Minister David Cameron was appointed president of Alzheimer's Research UK. [7]

Alzheimer's Research UK and Alzheimer's Society were the joint Charity of the Year for the 2019 Virgin Money London Marathon. The Dementia Revolution campaign raised £4 million, supporting research at the UK Dementia Research Institute. [8]

The charity reported a total income of £38.5m for the 12-month period ending March 2019, £36.7m of which was income from donations. [9]

In 2023, estimates made by Alzheimer's Research UK suggested that clinical trials for lecanemab and donanemab would only find 575,000 people living in the UK eligible for treatment. The challenge was, these people needed a diagnosis but the National Health Service couldn't deliver at that scale. This was because of the risks of side effects, few PET scanners to diagnose Alzheimer's and limited skilled professionals to perform lumbar punctures. [10]

See also

Related Research Articles

<span class="mw-page-title-main">Terry Pratchett</span> English fantasy author (1948–2015)

Sir Terence David John Pratchett was an English author, humorist, and satirist, best known for his 41 comic fantasy novels set on the Discworld, and for the apocalyptic comedy novel Good Omens (1990) which he wrote with Neil Gaiman.

<span class="mw-page-title-main">Dementia</span> Long-term brain disorders causing impaired memory, thinking and behavior

Dementia is a syndrome associated with many neurodegenerative diseases, which is characterized by a general decline in cognitive abilities that impacts a person's ability to perform everyday activities. This typically involves problems with memory, thinking, behavior, and motor control. Aside from memory impairment and a disruption in thought patterns, the most common symptoms include emotional problems, difficulties with language, and decreased motivation. The symptoms may be described as occurring in a continuum over several stages. Dementia ultimately has a significant effect on the individual, caregivers, and on social relationships in general. A diagnosis of dementia requires the observation of a change from a person's usual mental functioning and a greater cognitive decline than what is caused by normal aging.

Vascular dementia (VaD) is dementia caused by problems in the blood supply to the brain, resulting from a cerebrovascular disease. Restricted blood supply (ischemia) leads to cell and tissue death in the affected region, known as an infarct. The three types of vascular dementia are subcortical vascular dementia, multi-infarct dementia, and stroke related dementia. Subcortical vascular dementia is brought about by damage to the small blood vessels in the brain. Multi-infarct dementia is brought about by a series of mini-strokes where many regions have been affected. The third type is stroke related where more serious damage may result. Such damage leads to varying levels of cognitive decline. When caused by mini-strokes, the decline in cognition is gradual. When due to a stroke, the cognitive decline can be traced back to the event.

<span class="mw-page-title-main">Cancer Research UK</span> Cancer research and awareness charity

Cancer Research UK (CRUK) is the world's largest independent cancer research organisation. It is registered as a charity in the United Kingdom and Isle of Man, and was formed on 4 February 2002 by the merger of The Cancer Research Campaign and the Imperial Cancer Research Fund. Cancer Research UK conducts research using both its own staff and grant-funded researchers. It also provides information about cancer and runs campaigns aimed at raising awareness and influencing public policy.

<span class="mw-page-title-main">Frontotemporal dementia</span> Types of dementia involving the frontal or temporal lobes

Frontotemporal dementia (FTD), frontotemporal degeneration disease, or frontotemporal neurocognitive disorder encompasses several types of dementia involving the progressive degeneration of the brain's frontal and temporal lobes. FTDs broadly present as behavioral or language disorders with gradual onsets.

<span class="mw-page-title-main">Wellcome Trust</span> British healthcare research charity established in 1936

The Wellcome Trust is a charitable foundation focused on health research based in London, United Kingdom. It was established in 1936 with legacies from the pharmaceutical magnate Henry Wellcome to fund research to improve human and animal health. The aim of the Trust is to "support science to solve the urgent health challenges facing everyone." It had a financial endowment of £29.1 billion in 2020, making it the fourth wealthiest charitable foundation in the world. In 2012, the Wellcome Trust was described by the Financial Times as the United Kingdom's largest provider of non-governmental funding for scientific research, and one of the largest providers in the world. According to their annual report, the Wellcome Trust spent GBP £1.1 billion on charitable activities across their 2019/2020 financial year. According to the OECD, the Wellcome Trust's financing for 2019 development increased by 22% to US$327 million.

<span class="mw-page-title-main">British Heart Foundation</span> United Kingdom charity

The British Heart Foundation (BHF) is a cardiovascular research charity in the United Kingdom. It funds medical research related to heart and circulatory diseases and their risk factors, and runs influencing work aimed at shaping public policy and raising awareness.

<span class="mw-page-title-main">Alzheimer's Society</span> United Kingdom care and research charity

Alzheimer's Society is a United Kingdom care and research charity for people with dementia and their carers. It operates in England, Wales and Northern Ireland, while its sister charities Alzheimer Scotland and Alzheimer Society of Ireland cover Scotland and the Republic of Ireland respectively.

Parkinson's UK is a Parkinson's research and support charity in the United Kingdom. In April 2010, the Parkinson's Disease Society changed its name to become Parkinson's UK. Its aims are to improve the quality of life for people affected by Parkinson's and find a cure for the condition.

<span class="mw-page-title-main">The Brain Tumour Charity</span> British charity founded in 1996

The Brain Tumour Charity is a UK-based, Charity Commission registered, charity dedicated to funding research, raising awareness of brain tumours, reducing diagnosis times and providing support and information for people with brain tumours, their families and friends.

<span class="mw-page-title-main">Institute of Psychiatry, Psychology and Neuroscience</span> Research institution in London, England

The Institute of Psychiatry, Psychology & Neuroscience (IoPPN) is a leading centre for mental health and neuroscience research, education and training in Europe. It is dedicated to understanding, preventing and treating mental illness, neurological conditions, and other conditions that affect the brain. The IoPPN is a faculty of King's College London, England, and was previously known as the Institute of Psychiatry (IoP).

The Alzheimer Society of Ontario (ASO) is a care and research charity committed to helping people living with Alzheimer's disease and other dementias by:

Sir John Anthony Hardy is a human geneticist and molecular biologist at the Reta Lila Weston Institute of Neurological Studies at University College London with research interests in neurological diseases.

Alzheimer’s Disease International (ADI) is a not-for-profit, international federation of Alzheimer and dementia associations from around the world. The organization is in official relations with the World Health Organization (WHO). ADI advocates for people living with Alzheimer’s disease and all other types of dementia.

The INCTR Challenge Fund is the UK charity (Charity No. 1079181) raising funds for projects co-ordinated by the International Network for Cancer Treatment Research (INCTR) that improve the care delivered to cancer patients in developing countries and help reduce their suffering.

<span class="mw-page-title-main">UCL Queen Square Institute of Neurology</span> Academic institution in United Kingdom

The UCL Queen Square Institute of Neurology is an institute within the Faculty of Brain Sciences of University College London (UCL) and is located in London, United Kingdom. Together with the National Hospital for Neurology and Neurosurgery, an adjacent facility with which it cooperates closely, the institute forms a major centre for teaching, training and research in neurology and allied clinical and basic neurosciences.

<span class="mw-page-title-main">LifeArc</span>

LifeArc is a British life science medical research charity. It was established in 2000 as MRC Technology to translate the work of UK Medical Research Council (MRC) research scientists.

<span class="mw-page-title-main">Foundation for the National Institutes of Health</span>

The Foundation for the National Institutes of Health (FNIH) is a not-for-profit, 501(c)(3) charitable organization established by the US Congress in 1990. Located in North Bethesda, MD, the FNIH raises private-sector funds, and creates and manages alliances with public and private institutions in support of the mission of the National Institutes of Health (NIH).

Encephalitis Society is a not-for-profit organisation providing information and support for those affected by encephalitis, an inflammation of the brain, raising awareness and funding and collaborating on research on the condition.

<span class="mw-page-title-main">Dementia and Alzheimer's disease in Australia</span> Major health issue in Australia

Dementia and Alzheimer's disease in Australia is a major health issue. Alzheimer's disease is the most common type of dementia in Australia. Dementia is an ever-increasing challenge as the population ages and life expectancy increases. As a consequence, there is an expected increase in the number of people with dementia, posing countless challenges to carers and the health and aged care systems. In 2018, an estimated 376,000 people had dementia; this number is expected to increase to 550,000 by 2030 and triple to 900,000 by 2050. The dementia death rate is increasing, resulting in the shift from fourth to second leading cause of death from 2006 to 2015. It is expected to become the leading cause of death over the next number of years. In 2011, it was the fourth leading cause of disease burden and third leading cause of disability burden. This is expected to remain the same until at least 2020.

References

  1. "How much research we fund". Dementia Statistics Hub. Retrieved 6 January 2020.
  2. "History". Alzheimer's Research Trust. 13 March 2008. Archived from the original on 23 April 2008. Retrieved 13 March 2008.
  3. "Pratchett funds Alzheimer's study". BBC News. 13 March 2008. Archived from the original on 17 March 2008. Retrieved 13 March 2008.
  4. "The cost of dementia". Alzheimer's Research UK. Archived from the original on 1 September 2013. Retrieved 15 September 2013.
  5. "Dementia 'losing out' to cancer in funding stakes". BBC News. 3 February 2010. Retrieved 15 September 2013.
  6. "About us". UK Dementia Research Institute. 5 December 2018. Retrieved 6 December 2018.
  7. "David Cameron: I saw a world of darkness getting bigger and bigger". Financial Times. Retrieved 15 October 2021.
  8. "Dementia Revolution raises £4million". Charity Today News. 2 October 2019. Retrieved 6 January 2020.
  9. Kay, Liam. "Income at Alzheimer's Research UK has almost tripled in the past five years, accounts show". Third Sector . Retrieved 6 January 2020.
  10. "New Alzheimer's drugs offer hope for bleak diagnosis but remain out of reach in UK". Sky News. Retrieved 17 July 2023.